Search research articles
Contact Us
Filters
Showing results (411-420 of 421) with videos related to
Page
of 43
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 26, 1999
High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission
A Nademanee, A Molina, H Fung, et al.
Blood
|
February 26, 2000
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
A Krishnan, S Bhatia, M L Slovak, et al.
Leukemia
|
August 18, 2017
Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion
B Kumar, M Garcia, L Weng, et al.
Blood
|
April 27, 1999
Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy
G Somlo, I Sniecinski, A ter Veer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 22, 2003
Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed
H C Fung, S Cohen, R Rodriguez, et al.
Mbio
|
April 29, 2025
Role of glucuronoxylomannan and steryl glucosides in protecting against cryptococcosis
Gabriel Soares Matos, Samyr M Querobino, Veronica S Brauer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
November 24, 2025
Developing a Standardised National Model of Care for Treatment of Peanut Allergy in Infants: The ADAPT Peanut Oral Immunotherapy Program
T W Brettig, A Young, R Bhatia, et al.
Clinical Lymphoma
|
November 15, 2001
Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma
A Nademanee, A Molina, A Dagis, et al.
Leukemia
|
June 4, 2010
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
F J Giles, E Abruzzese, G Rosti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 17, 2003
A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome
H C Fung, A Stein, M l Slovak, et al.
Page
of 43
Search research articles
Search
Showing results (411-420 of 421) with videos related to
Sort By:
Page
of 43
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 26, 1999
High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission
A Nademanee, A Molina, H Fung, et al.
Blood
|
February 26, 2000
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
A Krishnan, S Bhatia, M L Slovak, et al.
Leukemia
|
August 18, 2017
Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion
B Kumar, M Garcia, L Weng, et al.
Blood
|
April 27, 1999
Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy
G Somlo, I Sniecinski, A ter Veer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 22, 2003
Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed
H C Fung, S Cohen, R Rodriguez, et al.
Mbio
|
April 29, 2025
Role of glucuronoxylomannan and steryl glucosides in protecting against cryptococcosis
Gabriel Soares Matos, Samyr M Querobino, Veronica S Brauer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
November 24, 2025
Developing a Standardised National Model of Care for Treatment of Peanut Allergy in Infants: The ADAPT Peanut Oral Immunotherapy Program
T W Brettig, A Young, R Bhatia, et al.
Clinical Lymphoma
|
November 15, 2001
Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma
A Nademanee, A Molina, A Dagis, et al.
Leukemia
|
June 4, 2010
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
F J Giles, E Abruzzese, G Rosti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 17, 2003
A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome
H C Fung, A Stein, M l Slovak, et al.
Page
of 43